Dr. Edward Pearce
Edward Pearce obtained his PhD for research on immunity to helminth parasites that he performed at NIMR, Mill Hill, London. He pursued postdoctoral training with Alan Sher at the NIH, where he focused on understanding Type 2 bias in immune responses during a variety of types of infection. He has been an independent investigator since 1990, holding faculty positions at Cornell University, University of Pennsylvania, Trudeau Institute, Washington University School of Medicine in St. Louis, and since 2015 has lived in Freiburg, Germany, where he is now a senior group leader at the Max Planck Institute of Immunobiology and Epigenetics and a Professor in the Faculty of Biology at the University of Freiburg. His research interests include Type 2 immunity, and a more recent focus on the role of cellular metabolism in immune cell function and fate during infection and cancer. He is particularly interested in understanding the relationship between metabolic reprogramming and differential cell activation and in identifying ways to inhibit or promote metabolic pathways to manipulate immune responses. His work is funded by the NIH and by the Max Planck Institute.